A detailed history of Newbridge Financial Services Group, Inc. transactions in Biovie Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 14,000 shares of BIVI stock, worth $38,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,000
Previous 17,000 17.65%
Holding current value
$38,780
Previous $9,000 44.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$0.4 - $0.56 $1,200 - $1,680
-3,000 Reduced 17.65%
14,000 $5,000
Q1 2024

Apr 24, 2024

BUY
$0.53 - $1.89 $5,830 - $20,790
11,000 Added 183.33%
17,000 $9,000
Q4 2023

Mar 28, 2024

BUY
$1.22 - $5.24 $6,100 - $26,200
5,000 Added 500.0%
6,000 $7,000
Q4 2022

Jan 17, 2023

BUY
$3.86 - $42.0 $3,860 - $42,000
1,000 New
1,000 $0

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $83.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.